Melitracen

Melitracen (brand names Melixeran, Trausabun) is a tricyclic antidepressant (TCA), for the treatment of depression and anxiety.^[1][2][3][4] In addition to single drug preparations, it is also available as Deanxit, marketed by Lundbeck, a combination product containing both melitracen and flupentixol.^[5][6][7][8]

Melitracen

Clinical data
Trade names	Adaptol, Dixeran, Melixeran, Thymeol, Trausabun
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral, intramuscular injection
ATC code	N06AA14 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 3-(10,10-dimethylanthracen-9(10H)-ylidene)-N,N-dimethylpropan-1-amine
CAS Number	5118-29-6 N
PubChem CID	25382
ChemSpider	23697 Y
UNII	Q7T0Y1109Z
KEGG	D08171 Y
ChEMBL	ChEMBL110094 Y
CompTox Dashboard (EPA)	DTXSID4048274
ECHA InfoCard	100.023.507
Chemical and physical data
Formula	C21H25N
Molar mass	291.438 g·mol−1
3D model (JSmol)	Interactive image
SMILES c3ccc2c(/C(c1c(cccc1)C2(C)C)=C/CCN(C)C)c3
InChI InChI=1S/C21H25N/c1-21(2)19-13-7-5-10-17(19)16(12-9-15-22(3)4)18-11-6-8-14-20(18)21/h5-8,10-14H,9,15H2,1-4H3 Y Key:GWWLWDURRGNSRS-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

The pharmacology of melitracen has not been properly investigated and is largely unknown, but it is likely to act in a similar manner to other TCAs. Indeed, melitracen is reported to have imipramine and amitriptyline-like effects and efficacy against depression and anxiety, though with improved tolerability and a somewhat faster onset of action.^[9][10]

See also

• Fluotracen
• Litracen
• Dimetacrine